Lonza Readies Phosphatidylserine 'Memree' Line

PS is a cognitive health ingredient that has shown potential to improve memory, concentration, and learning in human clinical trials. PS is the only ingredient authorized for a qualified FDA health claim for cognitive dysfunction and dementia in the elderly.

23 April 2012 --- Lonza Group Ltd. has officially launched Memree, the company’s new line of phosphatidylserine (PS) products. The company anticipated product launches last year, when they entered into a partnership with PS developer Lipogen Ltd. (Haifa, Israel).

PS is a cognitive health ingredient that has shown potential to improve memory, concentration, and learning in human clinical trials. PS is the only ingredient authorized for a qualified FDA health claim for cognitive dysfunction and dementia in the elderly.

The Memree PS product line includes MemreePS and MemreePlus, a combination of PS and phosphatidic acid that has demonstrated potential to reduce active levels of cortisol, a hormone associated with stress.

Lonza holds rights to market the phosphatidylserine ingredient in food, beverage, supplement, and medical food forms.

The company say phosphatidylserine has been widely studied as a cognitive health ingredient. The website for the product states that “numerous studies have shown that phosphatidylserine helps improve brain functions that decline with age. Specifically, PS has been shown to improve memory retention and support mental concentration. Furthermore, PS is the only cognitive health ingredient for which the FDA allows a qualified health claim.”